NGM BIOPHARMACEUTICALS INC Insider Trading for October 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NGM BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NGM BIOPHARMACEUTICALS INC for October 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.86 | 2,087 | 24,752 | 16,412,405 | 16.4 M to 16.4 M (+0.01 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 12.00 | 2,300 | 27,600 | 16,410,318 | 16.4 M to 16.4 M (+0.01 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.86 | 2,087 | 24,752 | 16,602,405 | 16.6 M to 16.6 M (+0.01 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 12.00 | 2,300 | 27,600 | 16,600,318 | 16.6 M to 16.6 M (+0.01 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.86 | 2,087 | 24,752 | 245,498 | 243.4 K to 245.5 K (+0.86 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.00 | 2,300 | 27,600 | 243,411 | 241.1 K to 243.4 K (+0.95 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.86 | 2,087 | 24,752 | 245,498 | 243.4 K to 245.5 K (+0.86 %) |
| Oct 24 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.00 | 2,300 | 27,600 | 243,411 | 241.1 K to 243.4 K (+0.95 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.94 | 43,400 | 518,196 | 16,408,018 | 16.4 M to 16.4 M (+0.27 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.29 | 34,721 | 392,000 | 16,364,618 | 16.3 M to 16.4 M (+0.21 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.62 | 6,818 | 72,407 | 16,329,897 | 16.3 M to 16.3 M (+0.04 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.94 | 43,400 | 518,196 | 16,598,018 | 16.6 M to 16.6 M (+0.26 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.29 | 34,721 | 392,000 | 16,554,618 | 16.5 M to 16.6 M (+0.21 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 10.62 | 6,818 | 72,407 | 16,519,897 | 16.5 M to 16.5 M (+0.04 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.94 | 43,400 | 518,196 | 241,111 | 197.7 K to 241.1 K (+21.95 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.29 | 34,721 | 392,000 | 197,711 | 163 K to 197.7 K (+21.30 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.62 | 6,818 | 72,407 | 162,990 | 156.2 K to 163 K (+4.37 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.94 | 43,400 | 518,196 | 241,111 | 197.7 K to 241.1 K (+21.95 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.29 | 34,721 | 392,000 | 197,711 | 163 K to 197.7 K (+21.30 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.62 | 6,818 | 72,407 | 162,990 | 156.2 K to 163 K (+4.37 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.94 | 43,400 | 518,196 | 16,408,018 | 16.4 M to 16.4 M (+0.27 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 11.29 | 34,721 | 392,000 | 16,364,618 | 16.3 M to 16.4 M (+0.21 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.62 | 6,818 | 72,407 | 16,329,897 | 16.3 M to 16.3 M (+0.04 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.94 | 43,400 | 518,196 | 16,598,018 | 16.6 M to 16.6 M (+0.26 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 11.29 | 34,721 | 392,000 | 16,554,618 | 16.5 M to 16.6 M (+0.21 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 10.62 | 6,818 | 72,407 | 16,519,897 | 16.5 M to 16.5 M (+0.04 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.94 | 43,400 | 518,196 | 241,111 | 197.7 K to 241.1 K (+21.95 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.29 | 34,721 | 392,000 | 197,711 | 163 K to 197.7 K (+21.30 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.62 | 6,818 | 72,407 | 162,990 | 156.2 K to 163 K (+4.37 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.94 | 43,400 | 518,196 | 241,111 | 197.7 K to 241.1 K (+21.95 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 11.29 | 34,721 | 392,000 | 197,711 | 163 K to 197.7 K (+21.30 %) |
| Oct 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.62 | 6,818 | 72,407 | 162,990 | 156.2 K to 163 K (+4.37 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 10.26 | 34,900 | 358,074 | 16,513,079 | 16.5 M to 16.5 M (+0.21 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 10.31 | 33,200 | 342,292 | 16,478,179 | 16.4 M to 16.5 M (+0.20 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 10.36 | 34,900 | 361,564 | 16,444,979 | 16.4 M to 16.4 M (+0.21 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.26 | 34,900 | 358,074 | 156,172 | 121.3 K to 156.2 K (+28.78 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.31 | 33,200 | 342,292 | 121,272 | 88.1 K to 121.3 K (+37.70 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.36 | 34,900 | 361,564 | 88,072 | 53.2 K to 88.1 K (+65.64 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.26 | 34,900 | 358,074 | 156,172 | 121.3 K to 156.2 K (+28.78 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.31 | 33,200 | 342,292 | 121,272 | 88.1 K to 121.3 K (+37.70 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.36 | 34,900 | 361,564 | 88,072 | 53.2 K to 88.1 K (+65.64 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.26 | 34,900 | 358,074 | 16,323,079 | 16.3 M to 16.3 M (+0.21 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.31 | 33,200 | 342,292 | 16,288,179 | 16.3 M to 16.3 M (+0.20 %) |
| Oct 16 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 10.36 | 34,900 | 361,564 | 16,254,979 | 16.2 M to 16.3 M (+0.22 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | 10% Owner | Buy | P | 10.57 | 17,724 | 187,343 | 16,410,079 | 16.4 M to 16.4 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | 10% Owner | Buy | P | 10.50 | 17,724 | 186,102 | 16,392,355 | 16.4 M to 16.4 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | 10% Owner | Buy | P | 10.26 | 17,724 | 181,848 | 16,374,631 | 16.4 M to 16.4 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | 10% Owner | Buy | P | 10.57 | 17,724 | 187,343 | 16,220,079 | 16.2 M to 16.2 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | 10% Owner | Buy | P | 10.50 | 17,724 | 186,102 | 16,202,355 | 16.2 M to 16.2 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | 10% Owner | Buy | P | 10.26 | 17,724 | 181,848 | 16,184,631 | 16.2 M to 16.2 M (+0.11 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.57 | 17,724 | 187,343 | 53,172 | 35.4 K to 53.2 K (+50.00 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.50 | 17,724 | 186,102 | 35,448 | 17.7 K to 35.4 K (+100.00 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.26 | 17,724 | 181,848 | 17,724 | 0 to 17.7 K |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.57 | 17,724 | 187,343 | 53,172 | 35.4 K to 53.2 K (+50.00 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.50 | 17,724 | 186,102 | 35,448 | 17.7 K to 35.4 K (+100.00 %) |
| Oct 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 10.26 | 17,724 | 181,848 | 17,724 | 0 to 17.7 K |